BioSpace News Archive

Deals

Mirati Therapeutics Announces Proposed Public Offering of Common Stock June 6, 2018

Mirati Therapeutics, Inc. (Nasdaq: MRTX) today announced that it intends to offer and sell, subject to market and other conditions, shares of its common stock.

June 6, 2018
·
4 min read
Jazz Pharmaceuticals to Present at the Goldman Sachs Global Healthcare Conference

Jazz Pharmaceuticals plc announced that the company will be webcasting its corporate presentation at the Goldman Sachs 39th Annual Global Healthcare Conference

June 6, 2018
·
1 min read
Genetown

Ironwood Pharmaceuticals to Present at the Goldman Sachs 39th Annual Global Healthcare Conference

Ironwood Pharmaceuticals, Inc. will present a corporate update at the Goldman Sachs 39th Annual Global Healthcare Conference

June 6, 2018
·
1 min read
Business

Biological Industries USA Adds Vitronectin XF™ to its Stem Cell Portfolio Through Agreement with Primorigen Biosciences, Inc.

Biological Industries USA and Primorigen Biosciences, Inc. announce a strategic partnership for non-exclusive worldwide distribution of Primorigen’s proprietary Vitronectin XF™ protein matrix for stem cell culture.

June 6, 2018
·
3 min read
Business

Amgen, Oklahoma Health Care Authority And University of Oklahoma’s Pharmacy Management Consultants Partner To Improve Medicaid Outcomes

Amgen’s First Public-Private Partnership with a State Medicaid Agency to Help Improve Patient Health Care Needs Through Data, Science and Information

June 6, 2018
·
4 min read
Deals

Viking Therapeutics Announces Proposed Public Offering of Common Stock June 6, 2018

Viking Therapeutics, Inc. announced that it intends to offer and sell, subject to market and other conditions, shares of its common stock in an underwritten public offering.

June 6, 2018
·
5 min read
Drug Development

Proteostasis Announces Positive Data from Ongoing Phase 1 Study of PTI-801 in Cystic Fibrosis Patients on Background Orkambi® Therapy

Proteostasis Therapeutics, Inc. announced positive results from the Company’s ongoing 14-day dosing study of PTI-801 in CF patients on background Orkambi® (lumacaftor/ivacaftor) therapy.

June 6, 2018
·
13 min read
Genetown

Vertex to Present at the Goldman Sachs Healthcare Conference on June 13

Vertex Pharmaceuticals Incorporated announced that management will present at the Goldman Sachs Healthcare Conference

June 6, 2018
·
1 min read
Genetown

Pfizer Opens Call for Proposals for Neuroscience Start-ups to Apply for LabCentral Residency

Pfizer Inc. opens a call for interested U.S. startup companies focused on neuroscience to submit non-confidential proposals for a Pfizer-sponsored LabCentral “Golden Ticket.”

June 6, 2018
·
7 min read
Biotech Bay

Arena Solutions Partners with eBOM to Launch Doc Connect for Arena, Streamlining Document Management

Integrated solution helps speed product delivery and improve documentation quality

June 6, 2018
·
2 min read